Publications by authors named "Gino Rojas"
Article Synopsis
- The study aims to compare left ventricular remodeling in patients with bicuspid aortic valve (BAV) versus those with trileaflet aortic valve (TAV) suffering from chronic aortic regurgitation (AR).
- Researchers analyzed 210 patients and found that BAV patients were generally younger and had milder AR compared to TAV patients, even though both groups had similar heart function overall.
- Key findings indicated that at mild AR levels, BAV patients showed larger left ventricular volumes, but this difference diminished at higher AR levels, revealing that demographic factors like age and weight are more significant than valve type in relation to heart size.
Article Synopsis
- The study investigated the effects of long-term use of RAAS inhibitors on hypertensive patients hospitalized with COVID-19, finding that nearly 74% of these patients were using such medications prior to hospitalization.
- Results showed that hypertensive patients had a higher mortality rate; however, those on RAAS inhibitors had a lower risk of death, and the use of these medications appeared to provide a protective benefit.
- The overall conclusion is that RAAS inhibitors may be beneficial for hypertensive COVID-19 patients, and continued use during hospitalization likely does not worsen outcomes, supported by a separate meta-analysis.
Article Synopsis
- * Out of 849 patients, nearly half were hypertensive; those on RAAS inhibitors before and during hospitalization had lower mortality rates than those not on these medications.
- * The analysis suggests that RAAS inhibitors may provide protective benefits for hypertensive COVID-19 patients, indicating that continuing these medications during treatment may not worsen outcomes.
Deterioration is sometimes unexpected in SARS-CoV2 infection. The aim of our study is to establish laboratory predictors of mortality in COVID-19 disease which can help to identify high risk patients. All patients admitted to hospital due to Covid-19 disease were included.
View Article and Find Full Text PDFArticle Synopsis
- - The study evaluated the impact of heart disease (HD) and cardiovascular medications on COVID-19 hospitalized patients, revealing that those with HD had higher mortality rates compared to those without (35.4% vs. 18.2%).
- - Among 859 patients, diabetes was particularly linked to increased risk of death, while common cardiovascular medications did not worsen patient outcomes; however, statins were associated with lower mortality rates.
- - The occurrence of cardiovascular events during hospitalization was linked to worse overall outcomes, with a mortality rate of 31.8% in patients who experienced such events compared to 19.3% in those who did not.